Treatment of latent tuberculosis infection in HIV infected persons (Q24247409)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Treatment of latent tuberculosis infection in HIV infected persons (English)

0 references

0 references

1 reference

1

0 references

author name string

Sara Woldehanna

series ordinal

2

0 references

publication date

26 January 2004

0 references

published in

0 references

cites work

No effect of isoniazid prophylaxis for purified protein derivative-negative HIV-infected adults living in a country with endemic tuberculosis: results of a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Interactions among drugs for HIV and opportunistic infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

American Thoracic Society. Diagnostic standards and classification of tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

Low antituberculosis drug concentrations in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB2

7 January 2021

10.1002/14651858.CD000171.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3983762

3983762

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference